Evidence map›Paper›PMID 19130224›Full record

ArticleDigestive diseases and sciences2009

Gastroprotective action of Cochinchina momordica seed extract is mediated by activation of CGRP and inhibition of cPLA(2)/5-LOX pathway.

Jung Mook Kang, Nayoung Kim, Bongcheol Kim, Joo-Hyon Kim, Bong-Yong Lee, Ji Hyun Park, Mi Kyoung Lee, Hye Seung Lee, In-Jin Jang, Joo Sung Kim and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Gastroprotective Effects of Paeonia Extract Mixture HT074 against Experimental Gastric Ulcers in Rats.Evidence-based complementary and alternative medicine : eCAM · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. CGRP receptor antagonism and migraine.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Jung Mook KangDepartment of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-744, South Korea.
Nayoung Kim
Bongcheol Kim
Joo-Hyon Kim
Bong-Yong Lee
Ji Hyun Park
Mi Kyoung Lee
Hye Seung Lee
In-Jin Jang
Joo Sung Kim
Hyun Chae Jung
In Sung Song
Seoul National University · KRSK Group (South Korea) · KRNew Generation University College · ETSeoul National University Bundang Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cochinchina momordica seed extract (SKMS10), which is composed of the major compounds momordica saponins, has been evaluated for its gastroprotective effects in rat models of acute gastric mucosal damage. Ethanol and water immersion restraint stress (WRS) induced gastric damage, including hemorrhages and edema, was significantly attenuated by pretreatment with SK-MS10. In addition, SK-MS10 reduced increases of mucosal myeloperoxidase (MPO), IL-1β, and TNFα levels and the expression of cPLA(2), and 5-LOX induced by ethanol or WRS. SK-MS10 also increased hexosamine, adherent mucus, and the expression of MUC5AC. Furthermore, SK-MS10 enhanced the mucosal expression of the CGRP gene and its serum levels.N(G)-methyl L-arginine (L-NMMA) or capsaicin desensitization reversed the SK-MS10-induced gastroprotection effect. These results suggest that SK-MS10 is a gastroprotective agent against acute gastric mucosal damage by suppressing proinflammatory cytokines, downregulating cPLA(2), 5-LOX, and increasing the synthesis of mucus. Furthermore, CGRP-NO pathway was found to play an important role in these gastroprotective effects of SK-MS10.

Indexed as

MomordicaAnimalsArachidonate 5-LipoxygenaseCalcitonin Gene-Related PeptideCyclooxygenase 2CytoprotectionDinoprostoneDisease Models, AnimalDown-RegulationEthanolGastric MucosaGastrointestinal AgentsGroup IV Phospholipases A2HexosaminesInflammation MediatorsInterleukin-1betaArachidonate 5-LipoxygenaseCalcitonin Gene-Related PeptideCyclooxygenase 2DinoprostoneEthanolGastrointestinal AgentsGroup IV Phospholipases A2HexosaminesInflammation MediatorsInterleukin-1betaLeukotriene B4Muc5ac protein, ratMuc6 protein, ratMucin 5ACMucin-6Nitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type INos1 protein, ratPeroxidasePla2g4a protein, ratPlant ExtractsPtgs2 protein, ratRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID19130224
OpenAlexW2067141531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.